Doctors! Tell us YOUR answer! How should the term “cure” be used in #kidneycancer? #ESMO25 Let’s see how many responses we can get! @DrChoueiri @montypal @DrYukselUrun @TiansterZhang @Uromigos @OncoAlert

#ESMO25 starts today! Excited to present #evidencebased data from @kcCURE exploring how metastatic #kidneycancer pts interpret the word “cure.”

Every patient is first a human being with a name, a story, a dream. Dignity is part of the treatment. Never reduce a life to a diagnosis…

🎉 Congratulations @ejasonabel who will receive the KCA's Andrew C. Novick Award at #IKCSNA25! This award recognizes excellence in #kidneycancer urology care. Read more: https://t.co/ud1wtMFOZB

@andyzwang @DrChoueiri @neerajaiims @montypal @PGrivasMDPhD @ERPlimackMD @KidneyCancer @kcCURE @kidneycan @utswcancer @UTSWHemeOnc @UTSW_RadOnc @ndesai2005 @ithinkichan @UTSWInternalMed @MalladiLab @JBrugarolas Supported by @DOD #KCRP Idea Development Award. We are grateful for the funding & the chance to make a difference for our patients w/ #kidneycancer. For more details please see our paper #MolecularCancer @BioMedCentral. https://t.co/qBHunE4Al1 #FIN

Last week @andyzwang & I published 1st of our translational research in #MolecularCancer @BioMedCentral, developing a multifunctional immunotherapy nanoparticle (MINP) to treat #kidneycancer. Thanks to #KinmanAu & #SiqingLi, 2 of our postdocs @utswcancer who did the work. 1/n

📣 Live at #ASCO25: Learn from real-world #RCC cases with @montypal, Dr. McDermott & @TiansterZhang  ✅ IO-based regimens  ✅ Sequencing therapies  ✅ Shared decision-making  🗓️ May 31 | 7:00 PM CDT  🔗

#ScientificTourDeForce and a brilliant demonstration of how much we can learn from outlier events and rare disease. #RMC The matrix of factors that impact immune function are vast, but not impenetrable, and offers avenues for immune based prevention. #WorthTheRead

Amsterdam • Keukenhof tulips, windmills, canals, and best of all, friends. Nothing better than getting to see great friends all together overseas. Missed being with everyone #IKCSEU25 but enjoyed dinner @TiansterZhang @RCCadvocate @MichaelStaehler

So proud of @MichaelStaehler for this well deserved honor. Your relentless commitment to improving patient care inspires me every day. 🧡

70% of health-related internet searches are zero-click - which means pts are relying on snippets and AI overviews for information. When you see something like this that is outdated, misleading, or both - click on the feedback button. It's a small way you can help improve

Exploring the burden of cancer in metastatic renal cell carcinoma (mRCC) 📊🧬 This study sheds light on the impact of mRCC on patients & healthcare systems. Don’t miss these key insights @ASCO #GU25! @RCCadvocate @kcCURE

Clear cell RCC is heterogeneous. @utswcancer’s @TiansterZhang presents the new frontier and dares us to imagine patients unique disease treated uniquely. #GU25 #kidneycancer #diseaseburdenzero

Great Poster by our friends at @kcCURE at #GU25 Spoke to First Author Dena Blattle @RCCadvocate who tells us more: Disease Burden in mRCC #kidneycancer pts spend HOURS⏳ thinking about #cancer. In last 9⃣0⃣ days, 36% have gone to ER. >1/3 of patients say that cancer

Burden of mRCC – Insights from KCCure survey 🛑 36% visited the ER, 23% hospitalized, 44% spend hours daily thinking about cancer 💊 1 in 3 worried about taking too many meds 🧬 More research needed to improve care & QoL! @kcCURE @RCCadvocate @ASCO @DrYukselUrun #GU25

Treatment free survival is becoming an important endpoint when looking at different #mRCC treatments. VEGF alone had shortest TFS. Something to be said about treatment breaks. Thx to #mehulgupta and #meredithregan @IMDConline @DrRanaMcKay @tompowles1 @DrChoueiri @EurUrolOncol

#kidneycancer Patients want to be cured. They will accept treatments that increase survival - but they want cure. Thanks @BraunMDPhD for continuing to repeat this mantra and for your efforts to make it a reality.

An honest piece worth reading on the value in building connections to create a network👇. True in science, & also life in general.

Thanks to #IKCSNA24 for prioritizing patient voices! @KidneyCancer “Patient-Centered Outcomes in Kidney Cancer Research” - Ask patients for their preferred appointment times - Find out what topics they want to discuss with their oncologist - Focus on new metrics to capture

Thank you for joining us at #IKCSNA24 and making this milestone 25-year anniversary special! Please save the dates for our upcoming meetings! ⭐ 2025 IKCS: Europe - Amsterdam, May 1-3 ⭐ 2025 IKCS: North Am - Denver, CO, Nov 13-15 See you again soon!